The question is no longer if the technologies used to develop products are viable, but how they will be regulated? In addition to price and achieving economies of scale, Lux Research identified regulatory approval as a principal challenge facing the cell-based meat category and noted that while Singapore’s approval in 2020 is a step in the right direction, there is still a lack of clarity on global regulations.